Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PVS-10200 for Restenosis in PAD (TRIUMPH)
NCT01099215Phase 2Completed
- Sponsor
- Takeda
- Start
- Apr 2010
- Primary completion
- Jun 2012
- Modality
- Implantable Devices, Implantable Hydrogels, Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of PVS-10200 in peripheral artery disease (PAD) (2 arms), sponsored by Takeda. Primary endpoint: Incidence of Major Adverse Events at 4 weeks. Started Apr 2010; status: completed.
02
Drugs
PVS-10200
03
Conditions
peripheral artery disease (PAD)
Beyond the preview
Go deeper on NCT01099215.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01099215.